Species- and tissue-dependent effects of NO and cyclic GMP on cardiac ion channels.
about
Cardiac cAMP: production, hydrolysis, modulation and detectionTherapeutic potential of PDE modulation in treating heart diseaseArginase induction and activation during ischemia and reperfusion and functional consequences for the heartRegulation of phosphodiesterase 3 and inducible cAMP early repressor in the heartAtrial natriuretic peptide regulates Ca channel in early developmental cardiomyocytesA Combined Approach Using Patch-Clamp Study and Computer Simulation Study for Understanding Long QT Syndrome and TdP in Women.Sinoatrial tissue of crucian carp heart has only negative contractile responses to autonomic agonistsConcerted regulation of cGMP and cAMP phosphodiesterases in early cardiac hypertrophy induced by angiotensin IINitroprusside modulates pulmonary vein arrhythmogenic activity.Cardiac cyclic nucleotide phosphodiesterases: function, regulation, and therapeutic prospects.Roles of cGMP-dependent protein kinase I (cGKI) and PDE5 in the regulation of Ang II-induced cardiac hypertrophy and fibrosis.Simvastatin attenuates the oxidative stress, endothelial thrombogenicity and the inducibility of atrial fibrillation in a rat model of ischemic heart failure.Targeting cyclic nucleotide phosphodiesterase in the heart: therapeutic implications.Urocortin 2 stimulates nitric oxide production in ventricular myocytes via Akt- and PKA-mediated phosphorylation of eNOS at serine 1177.Cyclic guanosine monophosphate compartmentation in rat cardiac myocytesRole of ion channels in sepsis-induced atrial tachyarrhythmias in guinea pigs.Vardenafil protects isolated rat hearts at reperfusion dependent on GC and PKGbeta3-adrenergic receptor activation increases human atrial tissue contractility and stimulates the L-type Ca2+ currentSERCA Cys674 sulphonylation and inhibition of L-type Ca2+ influx contribute to cardiac dysfunction in endotoxemic mice, independent of cGMP synthesis.Calcineurin-dependent ion channel regulation in heart.Cyclic GMP signaling in cardiovascular pathophysiology and therapeutics.Recent insights in the paracrine modulation of cardiomyocyte contractility by cardiac endothelial cells.Phosphodiesterases and cyclic GMP regulation in heart muscle.L-type CaV1.2 calcium channels: from in vitro findings to in vivo function.Sex hormonal regulation of cardiac ion channels in drug-induced QT syndromes.I(f) blocking potency of ivabradine is preserved under elevated endotoxin levels in human atrial myocytesA comparative study of changes of autophagy in rat models of CLP versus LPS induced sepsis.PDE2 activity differs in right and left rat ventricular myocardium and differentially regulates β2 adrenoceptor-mediated effects.PKG and PKC Are Down-Regulated during Cardiomyocyte Differentiation from Embryonic Stem Cells: Manipulation of These Pathways Enhances Cardiomyocyte Production.Hypotonic swelling promotes nitric oxide release in cardiac ventricular myocytes: impact on swelling-induced negative inotropic effect.The action of nitric oxide to enhance cell survival in chick cardiomyocytes is mediated through a cGMP and ERK1/2 pathway while p38 mitogen-activated protein kinase-dependent pathways do not alter cell death.Anti-arrhythmic effect of diosgenin in reperfusion-induced myocardial injury in a rat model: activation of nitric oxide system and mitochondrial KATP channel.The Role of Phosphodiesterase-2 in Psychiatric and Neurodegenerative Disorders.Toxicity of hydroxyurea in rats and dogs.Natriuretic peptides increase beta1-adrenoceptor signalling in failing hearts through phosphodiesterase 3 inhibition.Nitric oxide and ATP-sensitive potassium channels mediate lipopolysaccharide-induced depression of central respiratory-like activity in brain slices.Study of the regulation of the inotropic response to 5-HT4 receptor activation via phosphodiesterases and its cross-talk with C-type natriuretic peptide in porcine left atrium.Imaging of PDE2- and PDE3-Mediated cGMP-to-cAMP Cross-Talk in Cardiomyocytes.Roles of A-Kinase Anchoring Proteins and Phosphodiesterases in the Cardiovascular System.Phosphodiesterase 2A as a therapeutic target to restore cardiac neurotransmission during sympathetic hyperactivity.
P2860
Q26781612-29305F91-783B-4D9E-8341-475E3B46DBD2Q27005761-87534DA1-8FD8-42B8-95A3-BBCE60DC3ED2Q28081566-74331BA8-EE37-4CF7-9587-C6DDCD40E722Q28291007-1DC7098D-0F21-43E5-81EF-6A93735C8D71Q33526969-9671F855-22B6-402A-8985-926F28E0B37BQ33572254-CE32E05D-EDC7-4CB9-BEC0-54A1DEB915CDQ33601840-E0480912-A79C-4C07-9CD7-17D3DA5395AFQ33769656-B72A39A2-1022-4402-90FB-DCC11CFBF318Q33787307-0B62FD53-6280-42E6-80FD-C208FAC76C61Q33966155-6FF99D62-D0A7-4491-9D67-DCE767F93CA8Q34144673-2525FB01-C1E1-4660-B37E-863C75B922FDQ34158715-ACC82EEC-0C47-442C-A247-07630DD17910Q34252901-B98F0067-839D-4553-9FF6-CACCF103D9CAQ34296776-CBD7CE88-210D-43CC-9052-2CF82C6B0576Q35812341-816DB8FC-3FDA-4EB5-BBC3-95935230702EQ36153305-7D342CB4-0C3F-481B-AD3B-FC974514FA2AQ36735813-AE563392-027E-4F19-AD57-C351AC220AFBQ36835728-9401CBE6-9948-4661-901E-977697E89BB4Q37234941-619F731E-2861-4EA1-878F-B2AAC34EC411Q37315915-1674E912-073C-439C-BFCD-DB728857187BQ37420916-0A4855ED-4301-4E73-8956-D54F10ECE45EQ37679633-8716CD45-D647-4825-B91E-7947CF26601EQ38033089-B25B715B-C04B-4908-ABB8-E18A49A71555Q38175138-E6938DD1-7279-4C17-AC3E-B4215BB041CEQ38946612-051CBADD-9309-4B6C-A39B-C861F0397265Q40333918-67D084CF-49E1-49D1-B282-0CF6EADC2929Q41672517-1B2C3315-B487-4853-9969-24D18FF682D7Q42285592-528CB8DF-ED74-464F-B0AD-5A5855E071B2Q42399470-12B6BD78-3EDB-4943-9268-78D05D1AE593Q43107997-9203C20C-65A3-4E2D-8C0A-17F54FB2B9BEQ43661208-6E48C267-A236-4BD2-8467-CA928829C4CAQ43911293-619C20FA-0227-4A98-B0C9-C5C01809A0E4Q45068634-6B1B763D-D75C-4B4D-A3AF-D7D280E6A3B6Q46204887-2D84CD28-E44F-4F0F-9024-97F9F5EFCB71Q48412668-F23270F0-94EC-417F-952B-8C621DB27561Q48663869-74FD608A-87B5-45E0-8D88-44CC9835A972Q49168980-08C17BA6-5CDD-4CA9-9D1B-8AF9FDD443E0Q49787366-AE229384-80F1-45D8-9696-9EC8331F1594Q52809588-CFF527C1-7D14-4444-B6AE-94246FD64696Q55341491-DB832DF3-7117-4CCF-A62B-B6357C3F5778
P2860
Species- and tissue-dependent effects of NO and cyclic GMP on cardiac ion channels.
description
2005 nî lūn-bûn
@nan
2005年の論文
@ja
2005年論文
@yue
2005年論文
@zh-hant
2005年論文
@zh-hk
2005年論文
@zh-mo
2005年論文
@zh-tw
2005年论文
@wuu
2005年论文
@zh
2005年论文
@zh-cn
name
Species- and tissue-dependent effects of NO and cyclic GMP on cardiac ion channels.
@ast
Species- and tissue-dependent effects of NO and cyclic GMP on cardiac ion channels.
@en
type
label
Species- and tissue-dependent effects of NO and cyclic GMP on cardiac ion channels.
@ast
Species- and tissue-dependent effects of NO and cyclic GMP on cardiac ion channels.
@en
prefLabel
Species- and tissue-dependent effects of NO and cyclic GMP on cardiac ion channels.
@ast
Species- and tissue-dependent effects of NO and cyclic GMP on cardiac ion channels.
@en
P50
P1476
Species- and tissue-dependent effects of NO and cyclic GMP on cardiac ion channels.
@en
P2093
Francesca Rochais
Liliana Castro
P304
P356
10.1016/J.CBPB.2005.04.012
P577
2005-05-31T00:00:00Z